The petition urges the agency to do away with an “unnecessary” and “burdensome” regulatory framework that significantly limits access to this medication.

Four blue states are asking the U.S. Food and Drug Administration to remove restrictions on a key abortion medication and make it easier for clinicians to prescribe and dispense it - an attempt to widen access as the agency plans to review the pill’s safety.